Integrating Companion Diagnostic Assays into Drug Development: Addressing the Challenges from the Diagnostic Perspective
Author:
Affiliation:
1. bioMerieux, Inc; Cambridge; Massachusetts; 02142; USA
Publisher
Wiley
Subject
Drug Discovery
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ddr.21068/fullpdf
Reference6 articles.
1. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011
2. IMS Health Report 2012 The global use of medicines: outlook through 2016
3. Deconstructing the drug development process: the new face of innovation;Kaitin;Clin Pharmacol Ther,2010
4. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med,2010
5. Market access challenges in the EU for high medical value diagnostic tests;Miller;Personal Med,2011
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Analysis of recurrent research pathways for assessing and improving effectiveness in life sciences laboratories;2023-01-10
2. Integrating Diagnostic Products Into the Drug Development Workflow: Applications for Companion Diagnostics;Biotechnology Entrepreneurship;2020
3. Cost Implications of Value-Based Pricing for Companion Diagnostic Tests in Precision Medicine;PharmacoEconomics;2016-02-22
4. Geschäftsmodelle in der Personalisierten Medizin – Konzeptioneller Rahmen zum Status Quo und Perspektiven;Dienstleistungspotenziale und Geschäftsmodelle in der Personalisierten Medizin;2015
5. Tissue-Based Companion Diagnostics: Development of IHC Assays from an Industry Perspective;Methods in Pharmacology and Toxicology;2014
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3